Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-04-18

Clinical Trial Update: Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery [Phase 4]

View source ↗

Summary

A Phase 4 study investigating sphenopalatine ganglion block to prevent shoulder pain after laparoscopic bariatric surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Obesity | Phase 4 | Status: WITHDRAWN